HealthBeacon, a Dublin-based medical technology company that plans to float on the stock market with a valuation of €100 million, had revenues of €1.2 million in 2020 and recorded a loss from continuing operations of €3.4 million. The company, however, is predicting that it is on the brink of growing explosively from 4,585 units deployed in 2020 to 100,000 by the end of 2023. HealthBeacon has developed a solution that helps patients better adhere to injectable medications schedules across seven therapeutic areas such as respiratory, rheumatology, and neurology. It is selling 25 per cent of its shares to raise €25…

Join The Currency

SPECIAL OFFER.

€1 for 1 month

The Currency has turned 3 – and we are celebrating with a special offer.

Get full access to 3,700 interviews, investigations, columns, features and columns for the first month for just €1.

Or sign up for an annual membership at the reduced price of €200.

Cancel at any time.

To become a member today click here.